Sujatha Sistla

TL;DR: This systematic analysis aims to update RSV-associated acute lower respiratory infection morbidity and mortality at global, regional, and national levels in children aged 0–60 months for 2019, with focus on overall mortality and narrower infant age groups that are targeted by RSV prophylactics in development.

TL;DR: This article reviews the various aspects of VAP such as definition, risk factors, etiological agents, diagnosis, treatment and prevention with emphasis on the recent advances.

TL;DR: Emergency intubation and intravenous sedatives were found to be the specific risk factors for early onset VAP, while tracheostomy and re-intubation were the independent predictors of late-onset VAP by multivariate logistic regression analysis.

TL;DR: In this article, the authors report the prevalence and profiles of secondary infections and clinical outcomes in hospitalized critically ill coronavirus disease 2019 (COVID-19) patients in India.

TL;DR: Increasing prevalence of MDR pathogens in patients with late-onset VAP indicate that appropriate broad-spectrum antibiotics should be used to treat them, and production of ESBL, AmpC beta-lactamases and metallo beta-bacteria were responsible for the multi-drug resistance of these pathogens.